Replies to post #279789 on Avid Bioservices Inc (CDMO)

[Protector]

goodJohn, that is incorrect. Bavituximab performed as expected. See official communications on the topic.

Sunrise was not sabotaged. It was stopped for futility, and even though the control arm exceeded history, Bavituximab performed below that and placebo.

If the control arm doesn't exceed then the trial wouldn't have been stopped and the stat. sig. improvement that PPHM communicated later would have been obtained in a blinded way good to file for approval.

So pls don't say it doesn't matter.